STOCK TITAN

Whitehawk Therapeutics, Inc. (WHWK) Net Income by Year

WHWK

Whitehawk Therapeutics, Inc. reported a net loss of $20.6M in fiscal year 2025. This represents an increase of 67.7% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Whitehawk Therapeutics, Inc. has filed alongside them.

FY2025 annual
Net Income -$20.6M
YoY +67.7%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

WHWK Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$20.6M+67.7%-$63.7M+3.2%-$65.8M-8.7%-$60.5M+45.0%-$110.1M-3065.3%-$3.5M+85.1%-$23.3M-123.8%-$10.4M+51.4%-$21.4MN/A-$31KN/A-$29K-4.9%-$27K-0.7%-$27K

WHWK Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$16.6M+68.4%-$22.2M-130.4%N/A-$17.7M-41.4%-$52.6M-260.8%$73.0M+499.2%-$18.3M-12.3%-$12.5M+23.0%-$14.6M+18.9%-$18.3M-20.1%-$16.3M-16.9%-$16.3M-12.6%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Whitehawk Therapeutics, Inc. financials

Frequently Asked Questions

What was Whitehawk Therapeutics, Inc.'s net income in fiscal year 2025?

Whitehawk Therapeutics, Inc. reported a net loss of $20.6M in fiscal year 2025.

How fast is Whitehawk Therapeutics, Inc.'s net income growing?

Whitehawk Therapeutics, Inc. (WHWK) net income rose by 67.7% year over year, from -$63.7M to -$20.6M in fiscal year 2025.

How has Whitehawk Therapeutics, Inc.'s net income changed over the years?

Across the 15 fiscal years this page covers, Whitehawk Therapeutics, Inc. (WHWK) net income went from -$27K in fiscal year 2011 to -$20.6M in fiscal year 2025.

Whitehawk Therapeutics, Inc. (WHWK) reported -$16.6M in net income in Q2 2026. This represents an increase of 68.4% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Whitehawk Therapeutics, Inc. (WHWK) reported on that line in every period on record.